Amit V. Khera, MD, MSc, associate director of the Precision Medicine Unit at the Massachusetts General Hospital Center for Genomics Medicine and the Cardiovascular Disease Initiative at the Broad Institute, discusses the potential impact of polygenic scores.
Zirui Song, MD, PhD, an assistant professor of health care policy and medicine at Harvard Medical School and an internal medicine physician at Massachusetts General Hospital, discusses workplace wellness programs.
Mara Bloom, JD, MS, the executive director of Mass General Cancer Center, discusses the future of cancer care delivery, grappling with cost, and access to clinical trials.
Justin F. Gainor, MD, director of targeted immunotherapy at Massachusetts General Hospital and assistant professor of medicine at Harvard Medical School, answers three questions about cancer immunotherapy.
Hera Vlamakis, PhD, senior group leader for the Infectious Disease and Microbiome Program at the Broad Institute, discusses the expanding impact of gut microbiome research.
Elaine B. Goodman, MD, MBA, medical director of the Medical Walk-In Unit at Massachusetts General Hospital and associate chief medical officer at Wellframe, discusses sustained engagement and impact for digital health solutions.
Michael Chernew, director of the Healthcare Markets and Regulation Lab at Harvard Medical School, discusses intersections between approaches to slowing health care spending and real-world experience.
Kenneth Mandl, MD, MPH, director of the Computational Health Informatics Program at Boston Children's Hospital, discusses opportunities, limits and hurdles for health care data apps.
Ateev Mehrotra, MD, MPH, associate professor of healthcare policy at Harvard Medical School discusses striking growth and potential savings in telehealth with HMS Executive Education.
